THOMAS MCGAULEY - 30 Jan 2026 Form 4 Insider Report for TENAX THERAPEUTICS, INC. (TENX)

Role
Interim CFO
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact
Issuer symbol
TENX
Transactions as of
30 Jan 2026
Net transactions value
$0
Form type
4
Filing time
03 Feb 2026, 17:57:56 UTC
Previous filing
19 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MCGAULEY THOMAS Interim CFO 101 GLEN LENNOX DRIVE SUITE 300, CHAPEL HILL /s/ S. Halle Vakani, as Attorney-in-Fact 03 Feb 2026 0001550701

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TENX Common Stock 2,000 30 Jan 2026 Direct
holding TENX Common Stock 1,000 30 Jan 2026 By Child
holding TENX Common Stock 5,000 30 Jan 2026 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TENX Stock Option (right to buy) Options Exercise $0 +50,000 $0.000000 50,000 30 Jan 2026 Common Stock 50,000 $12.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable with 50% vesting January 30, 2026 and 50% vesting on May 31, 2026, subject to the Reporting Person's continuous service to the Issuer.